|
SEC24D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62614366416847E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.73772149184515E-12 |
| Normal-vs-Stage2 |
2.80269999985983E-07 |
| Normal-vs-Stage3 |
5.19610021676442E-10 |
| Normal-vs-Stage4 |
6.27479956882837E-10 |
| Stage1-vs-Stage2 |
4.625600E-01 |
| Stage1-vs-Stage3 |
2.461000E-01 |
| Stage1-vs-Stage4 |
6.249700E-02 |
| Stage2-vs-Stage3 |
8.495200E-01 |
| Stage2-vs-Stage4 |
4.183400E-01 |
| Stage3-vs-Stage4 |
4.813000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.127850E-02 |
| Normal-vs-Asian |
8.485900E-02 |
| Caucasian-vs-AfricanAmerican |
2.92030000004218E-06 |
| Caucasian-vs-Asian |
8.462400E-01 |
| AfricanAmerican-vs-Asian |
2.351600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44249065417534E-15 |
| Normal-vs-Female |
3.71014330369235E-12 |
| Male-vs-Female |
3.289800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.560800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.63002944475465E-12 |
| Normal-vs-Age(61-80Yrs) |
1.86040072236437E-12 |
| Normal-vs-Age(81-100Yrs) |
1.802770E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.693400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.539600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.448200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.253400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.619790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.789400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.219440E-03 |
| Normal-vs-Grade 2 |
4.25104396128972E-13 |
| Normal-vs-Grade 3 |
1.71018754713259E-12 |
| Normal-vs-Grade 4 |
1.03669961504238E-10 |
| Grade 1-vs-Grade 2 |
3.675400E-01 |
| Grade 1-vs-Grade 3 |
4.385200E-01 |
| Grade 1-vs-Grade 4 |
3.125900E-02 |
| Grade 2-vs-Grade 3 |
8.144800E-01 |
| Grade 2-vs-Grade 4 |
4.611700E-02 |
| Grade 3-vs-Grade 4 |
3.303900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.02755606643268E-12 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
1.591990E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.43849426498855E-15 |
| Normal-vs-N1 |
1.943900E-03 |
| N0-vs-N1 |
7.620100E-02 |
|
|
